06
Aug
Global healthcare major Johnson & Johnson on Friday said it has applied for Emergency Use Authorization (EUA) of its single-dose COVID-19 vaccine in India. Earlier the company had said that it remained committed to bringing its single-dose COVID-19 vaccine to India and looks forward to ongoing discussions with the Indian government. The vaccine despite being declared by the US Centers for Disease Control and Prevention (CDC) that it had high efficacy at preventing hospitalisation and death in people ran into one hurdle after another. "On August 5, 2021, Johnson & Johnson Pvt. Ltd applied for Emergency Use Authorisation (EUA) of…
